2.75
+0.065(+2.43%)
Currency In USD
| Previous Close | 2.68 |
| Open | 2.67 |
| Day High | 2.79 |
| Day Low | 2.65 |
| 52-Week High | 10.79 |
| 52-Week Low | 2.56 |
| Volume | 385,697 |
| Average Volume | 586,233 |
| Market Cap | 172.65M |
| PE | -3.61 |
| EPS | -0.76 |
| Moving Average 50 Days | 5.24 |
| Moving Average 200 Days | 6.51 |
| Change | 0.07 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $107.52 as of December 04, 2025 at a share price of $2.745. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $112.32 as of December 04, 2025 at a share price of $2.745.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Announces Participation in Two Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 07, 2025 1:05 PM GMT
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 8:05 PM GMT
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
GlobeNewswire Inc.
Sep 10, 2025 11:05 AM GMT
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defo